Kronos Bio to reduce workforce by 83% as part of cost-cutting efforts while exploring strategic alternativees. Kronos Bio, Inc. KRON shares are trading higher on Wednesday in the premarket session.

Shares of cancer therapy developer Kronos Bio Inc. ($KRON) surged over 13% to hit their highest level since Nov. 6, with trading volume spiking more than six times ...

The latest update is out from Kronos Bio ( (KRON)). Kronos Bio, Inc. is undergoing a significant transformation with an 83% workforce reduction aimed at strategic cost containment by December 31 ...

The company has also disclosed a significant workforce reduction, aiming to cut 83% of its employees by the end of 2024. The decision is part of Kronos Bio's ongoing strategy to reduce costs while ...

In addition to the leadership shift, Kronos Bio revealed plans for a major workforce reduction. Approximately 83% of its employees will be laid off by the end of the year. This decision aligns ...